Internal Medicine, Nephrology · Kansas City, KS
NPI
1770783318
Since 2007
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
3901 Rainbow Blvd, Ms 3002
Kansas City, KS, 66160
Phone (913) 588-6074
Groups this clinician bills Medicare through
Medicare paid, 2024
$141K
1,515 services
Medicare patients, 2024
367
Average age 70
Drug cost, 2024
$1.2M
506 prescriptions
Company payments, 2025
$2,668
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ahmad M Tuffaha was code 99233 (hospital e&m - subsequent), 419 times for 110 patients. In total Ahmad M Tuffaha billed 1,515 services in 17 codes, and Medicare paid $141K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-04-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 419 | 110 | $91.08 | $38K |
| 99232 Hospital E&M - Subsequent | Facility | 304 | 86 | $60.48 | $18K |
| 99223 Hospital E&M - Initial | Facility | 100 | 93 | $133.00 | $13K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 100 | 85 | $12.04 | $1,204 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 86 | 64 | $12.61 | $1,085 |
| 90960 ESRD Related Services (not dialysis) | Office | 85 | 37 | $291.56 | $25K |
| 99291 Critical Care E&M | Facility | 84 | 20 | $161.84 | $14K |
| 99215 Office E&M - Established | Facility | 78 | 63 | $105.28 | $8,212 |
| 99215 Office E&M - Established | Office | 77 | 54 | $111.05 | $8,551 |
| 99214 Office E&M - Established | Facility | 47 | 43 | $66.69 | $3,135 |
| 90935 Hemodialysis | Facility | 28 | 26 | $54.56 | $1,528 |
| 99214 Office E&M - Established | Office | 24 | 21 | $64.53 | $1,549 |
| 90937 Hemodialysis | Facility | 17 | 12 | $78.66 | $1,337 |
| 99205 Office E&M - New | Facility | 14 | 14 | $135.31 | $1,894 |
By year: 2022 $172K for 1,797 services; 2023 $160K for 1,561 services; 2024 $141K for 1,515 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ahmad M Tuffaha prescribed most often to Medicare patients was Furosemide, with 71 prescriptions and refills. In total Ahmad M Tuffaha wrote 506 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Furosemide Generic | 71 | 150 | 26 | $285 |
| Fabrazyme Agalsidase Beta | 48 | 48 | Under 11 | $787K |
| Losartan Potassium Generic | 44 | 109 | 11 | $254 |
| Amlodipine Besylate Generic | 41 | 79 | Under 11 | $200 |
| Carvedilol Generic | 37 | 63 | Under 11 | $168 |
| Potassium Chloride Generic | 34 | 63 | Under 11 | $1,769 |
| Lisinopril Generic | 26 | 78 | Under 11 | $130 |
| Calcitriol Generic | 23 | 49 | Under 11 | $187 |
| Metolazone Generic | 22 | 41 | Under 11 | $453 |
| Galafold Migalastat Hcl | 13 | 13 | Under 11 | $384K |
| Clonidine Hcl Generic | 12 | 12 | Under 11 | $209 |
| Metoprolol Succinate Generic | 12 | 14 | Under 11 | $167 |
| Hydralazine Hcl Generic | 11 | 29 | Under 11 | $154 |
Brand drugs: 98 claims; generic drugs: 408 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ahmad M Tuffaha $2,668 ($2,668 in general payments such as food, travel and fees) from 2 companies. The largest payer was Genzyme Corporation with $2,668.
| Company | Payments | Amount |
|---|---|---|
| Genzyme Corporation SNY | 1 | $2,668 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.